# Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital

**Authors:** Alicia Rodríguez-Gascón, Yanire Lloréns-Villar, María Ángeles Solinís, Helena Barrasa, Andrés Canut-Blasco

PMC · DOI: 10.1007/s10096-024-04792-0 · 2024-03-09

## TL;DR

This study compared two hospital ICUs to see if a digestive decontamination protocol affects antibiotic resistance, finding no major impact.

## Contribution

The study provides a long-term comparison of antibiotic resistance in ICUs with and without SDD in the same hospital.

## Key findings

- SDD-ICU showed lower resistance in E. coli and E. faecalis to certain antibiotics.
- No SDD-ICU saw increased resistance in CoNS to linezolid.
- Patient type, not SDD, influenced resistance rates and ICU ecology.

## Abstract

The aim of this study was to to compare the antimicrobial resistance rate and its relationship with the antibiotic consumption in two separate Intensive Care Units (ICUs) of the same hospital, one with and other without selective decontamination of the digestive tract (SDD).

We performed a retrospective study in the two ICUs of the Araba University Hospital. Trauma and neurosurgical patients are admitted to the SDD-ICU, and general digestive surgery patients go to the no SDD-ICU. From 2014 to 2018 we analyzed the number of isolates, and the bacterial resistance trends of 47 antimicrobial-microorganism combinations. Additionally, antimicrobial consumption was estimated in both ICUs. Resistance rates were also compared with those reported in ENVIN-HELICS Spanish national registry.

In the ICU with SDD protocol, there was a significant decrease in the resistance of E. coli to amoxicillin/clavulanic acid and in the resistance of E. faecalis to high concentration of gentamycin and high concentration of streptomycin. A significant increase of resistance of Staphylococcus coagulasa negative (CoNS) to linezolid in the no SDD-ICU was also detected. Overall, the level of resistance in the SDD-ICU was lower or of the same order than in the ICU without SDD and that reported in the Spanish national registry.

SDD had neither a clinically relevant impact on emergence and spread of resistance, nor in the overall systemic antimicrobial use. The patient type rather than the SDD protocol showed to condition the ecology and therefore, the resistance rate in the ICUs.

The online version contains supplementary material available at 10.1007/s10096-024-04792-0.

## Linked entities

- **Chemicals:** amoxicillin/clavulanic acid (PubChem CID 6435924), gentamycin (PubChem CID 3467), streptomycin (PubChem CID 5297), linezolid (PubChem CID 3929)

## Full-text entities

- **Diseases:** Trauma (MESH:D014947)
- **Chemicals:** streptomycin (MESH:D013307), linezolid (MESH:D000069349), amoxicillin/clavulanic acid (MESH:D019980), gentamycin (MESH:D005839)
- **Species:** Enterococcus faecalis (species) [taxon 1351], Escherichia coli (E. coli, species) [taxon 562], Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11108900/full.md

---
Source: https://tomesphere.com/paper/PMC11108900